Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
Gilead Sciences Inc (NASDAQ:GILD) has exercised its option to license Nurix Therapeutics Inc’s (NASDAQ:NRIX) investigational targeted protein degrader molecule NX-0479 exclusively. This…
Benzinga Bulls And Bears: Tesla, Amazon, Meta And Shiba Inu Developer Admits To Big Mistake
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Barron’s Top Weekend Stock Picks: JP Morgan, Microsoft, Newmont And Why Apple Is Climbing As Banks Collapse
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Dan Niles Rings The Register On Meta, What Led The Manager To Sell?
Dan Niles, founder and portfolio manager of Satori Fund, tweeted Thursday that he trimmed Satori Fund’s position in Meta Platforms Inc (NASDAQ: META), citing a poor risk-reward outlook in the near term.
BeiGene Will Not Go Forward With Licensing Pact For Leap Therapeutics’ Lead Cancer Candidate
Leap Therapeutics Inc (NASDAQ:LPTX) announced BeiGene Ltd’s (NASDAQ:BGNE) option under the Exclusive Option, and License Agreement granting rights in certain Asian…
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Pfizer Inc (NYSE:PFE) and Astellas Pharma Inc (OTC:ALPMY) released topline results from the Phase 3 EMBARK trial evaluating Xtandi (enzalutamide) in non-metastatic hormone-sensitive…
FDA Advisory Committee Votes Favoring Pfizer’s COVID-19 Pill Paxlovid
The FDA’s Antimicrobial Drugs Advisory Committee voted 16-1 that available data support the safety and effectiveness of Pfizer Inc’s (NYSE:PFE) Paxlovid for…
FDA Approves Novartis’ Tafinlar + Mekinist For Pediatric Brain Cancer With Certain Mutations
The FDA has approved Novartis AG’s (NYSE:NVS) Tafinlar (dabrafenib) + Mekinist (trametinib) for pediatric patients one year of age and older…
Novo Nordisk Suspended From UK Trade Association For Practice Breaches
Novo Nordisk A/S (NYSE:NVO) has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two…